Manager, Primary Market Research |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
9月 30, 2024 |
Medical Science Liaison, Immunology |
Chongqing (Chongqing Province) |
China |
International |
Innovative Medicines |
Research & Development |
9月 30, 2024 |
Global Labeling Compliance & Project Lead |
London (The Westworks) |
United Kingdom |
Development |
Innovative Medicines |
Research & Development |
9月 30, 2024 |
DDIT Dev Dir Clinical Development |
Barcelona Gran Vía |
Spain |
Operations |
CTS |
Technology Transformation |
9月 30, 2024 |
Senior External Workforce Management PMO |
Prague |
Czech Republic |
People & Organization |
CTS |
Human Resources |
9月 30, 2024 |
Spec. DDIT ISC QNova |
Hyderabad (Office) |
India |
Operations |
CTS |
Technology Transformation |
9月 30, 2024 |
Associate Director DDIT ISC CSOC Engineering |
Hyderabad (Office) |
India |
Operations |
CTS |
Technology Transformation |
9月 30, 2024 |
Source to Pay Global Process Owner - Lead Reporting & Analytics |
Prague |
Czech Republic |
Finance |
CTS |
Audit & Finance |
9月 30, 2024 |
Associate Director AWS D&A Platform Analytics |
Hyderabad (Office) |
India |
Operations |
CTS |
Technology Transformation |
9月 30, 2024 |
Global Labelling Systems & Project Lead |
London (The Westworks) |
United Kingdom |
Development |
Innovative Medicines |
Research & Development |
9月 30, 2024 |
Senior Specialist DDIT ISC Detection & Response |
Hyderabad (Office) |
India |
Operations |
CTS |
Technology Transformation |
9月 30, 2024 |
Innovation Manager |
Hyderabad (Office) |
India |
Operations |
Innovative Medicines |
Quality |
9月 30, 2024 |
Associate Director DDIT ISC Detection & Response |
Hyderabad (Office) |
India |
Operations |
CTS |
Technology Transformation |
9月 30, 2024 |
External Workforce Management CoE Lead |
Prague |
Czech Republic |
People & Organization |
CTS |
Human Resources |
9月 30, 2024 |
Human Resources Services Expert with German |
Prague |
Czech Republic |
People & Organization |
CTS |
Human Resources |
9月 30, 2024 |
Clinical Development Medical Director - Rheumatology |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
9月 30, 2024 |
Werkstudent (w/m/d) im Bereich Medical Statistics / Epidemiology / Health Statistics |
Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) |
Germany |
International |
Innovative Medicines |
Others |
9月 30, 2024 |
Chef de Projet Ingénierie (h/f) |
Huningue |
France |
Operations |
Innovative Medicines |
Technical Operations |
9月 30, 2024 |
Account Management Lead |
Santo Amaro |
Brazil |
International |
Innovative Medicines |
Sales |
9月 30, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shenyang (Liaoning Province) |
China |
International |
Innovative Medicines |
Sales |
9月 30, 2024 |
县域主任/县域主管 |
Chaoyang (Liaoning Province) |
China |
International |
Innovative Medicines |
Sales |
9月 30, 2024 |
MR |
Quanzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
9月 30, 2024 |
MR |
Haikou (Hainan Province) |
China |
International |
Innovative Medicines |
Sales |
9月 30, 2024 |
(高级)医药代表 /(资深)产品专员 |
Tianjin (Tianjin) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |
(高级)医药代表 /(资深)产品专员 |
Nanjing (Jiangsu Province) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |
Lead Consultant – M&A Post-merger Integrations | Separations |
Prague |
Czech Republic |
Operations |
CTS |
BD&L & Strategic Planning |
9月 29, 2024 |
Lead Consultant |
Prague |
Czech Republic |
Operations |
CTS |
BD&L & Strategic Planning |
9月 29, 2024 |
Clinical Operations Specialist |
Prague |
Czech Republic |
Operations |
CTS |
Research & Development |
9月 29, 2024 |
Senior Consultant |
Prague |
Czech Republic |
Operations |
CTS |
BD&L & Strategic Planning |
9月 29, 2024 |
Clinical Project Manager |
Prague |
Czech Republic |
Operations |
CTS |
Research & Development |
9月 29, 2024 |
(高级)医药代表 /(资深)产品专员 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |
Medical Safety Expert |
Hyderabad (Office) |
India |
Development |
Innovative Medicines |
Research & Development |
9月 29, 2024 |
(高级)医药代表 /(资深)产品专员 |
Tianjin (Tianjin) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |
(高级)医药代表 /(资深)产品专员 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |
(高级)医药代表 /(资深)产品专员 |
Tianjin (Tianjin) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |
(高级)医药代表 /(资深)产品专员 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |
(高级)医药代表 /(资深)产品专员 |
Tianjin (Tianjin) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |
(高级)医药代表 /(资深)产品专员 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |
(高级)医药代表 /(资深)产品专员 |
Tianjin (Tianjin) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |
(高级)医药代表 /(资深)产品专员 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |
(高级)医药代表 /(资深)产品专员 |
Tianjin (Tianjin) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |
(高级)医药代表 /(资深)产品专员 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |
(高级)医药代表 /(资深)产品专员 |
Tianjin (Tianjin) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |
(高级)医药代表 /(资深)产品专员 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |
(高级)医药代表 /(资深)产品专员 |
Tianjin (Tianjin) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |
(高级)医药代表 /(资深)产品专员 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |
(高级)医药代表 /(资深)产品专员 |
Tianjin (Tianjin) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |
(高级)医药代表 /(资深)产品专员 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |
(高级)医药代表 /(资深)产品专员 |
Tianjin (Tianjin) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |
(高级)医药代表 /(资深)产品专员 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
9月 29, 2024 |